Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Geba

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Preventive Cardiology|September 16, 2024
Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real worldDana J Murdock, Keran Moll, Robert J Sanchez, et al.
Archives of Dermatological Research|May 28, 2009
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumabRobert Bissonnette, Richard G Langley, Kim Papp, et al.
Osteoarthritis and Cartilage|July 11, 2026
Signals for mineralization and inflammation are observed following treatment with fasinumab, a specific nerve growth factor inhibitorPoulabi Banerjee, Stephen J DiMartino, Haitao Gao, et al.
Clinical Therapeutics|May 23, 2002
Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trialDavid J Chang, Paul J Desjardins, Erluo Chen, et al.
Current Medical Research and Opinion|June 18, 2004
Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trialDavid J Chang, Paul J Desjardins, Steven R Bird, et al.
The Journal of Pain|November 19, 2003
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trialCharles A Birbara, Anthony D Puopolo, David R Munoz, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 2, 2015
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakersMichael D Ezekowitz, Kenneth A Ellenbogen, John P DiMarco, et al.
The Journal of Pain|November 24, 2004
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trialsWendy P Battisti, Nathaniel P Katz, Arthur L Weaver, et al.
Infectious Diseases and Therapy|July 3, 2024
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual ActivitiesDiana Rofail, Mohamed Hussein, Ulrike Naumann, et al.
Cancer Medicine|July 17, 2023
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trialsKusha A Mohammadi, Taylor Brackin, Gregory G Schwartz, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Preventive Cardiology|September 16, 2024
Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real worldDana J Murdock, Keran Moll, Robert J Sanchez, et al.
Archives of Dermatological Research|May 28, 2009
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumabRobert Bissonnette, Richard G Langley, Kim Papp, et al.
Osteoarthritis and Cartilage|July 11, 2026
Signals for mineralization and inflammation are observed following treatment with fasinumab, a specific nerve growth factor inhibitorPoulabi Banerjee, Stephen J DiMartino, Haitao Gao, et al.
Clinical Therapeutics|May 23, 2002
Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trialDavid J Chang, Paul J Desjardins, Erluo Chen, et al.
Current Medical Research and Opinion|June 18, 2004
Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trialDavid J Chang, Paul J Desjardins, Steven R Bird, et al.
The Journal of Pain|November 19, 2003
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trialCharles A Birbara, Anthony D Puopolo, David R Munoz, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 2, 2015
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakersMichael D Ezekowitz, Kenneth A Ellenbogen, John P DiMarco, et al.
The Journal of Pain|November 24, 2004
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trialsWendy P Battisti, Nathaniel P Katz, Arthur L Weaver, et al.
Infectious Diseases and Therapy|July 3, 2024
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual ActivitiesDiana Rofail, Mohamed Hussein, Ulrike Naumann, et al.
Cancer Medicine|July 17, 2023
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trialsKusha A Mohammadi, Taylor Brackin, Gregory G Schwartz, et al.
Pageof 7